Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 3/2019

01-07-2019 | Letter to the Editor

Tumor Associated Tissue Eosinophilia in Ameloblastoma

Authors: Gargi S. Sarode, Sachin C. Sarode, Amol R. Gadbail, Shailesh Gondivkar, Shankargouda Patil

Published in: Pathology & Oncology Research | Issue 3/2019

Login to get access

Excerpt

Tumor-associated tissue eosinophilia (TATE) is characterized by the presence of eosinophils as a component of peri- and intratumoral inflammatory infiltrate. It has been reported in various malignancies like colorectal, breast, ovarian, cervical, naso-pharynx, lungs, gastrointestinal, skin, genitourinary, Hodgkin’s and prostate cancer [1]. In oral cavity, tissue eosinophilia is reported in oral squamous cell carcinoma [2], odontogenic cysts [3] and mucoepidermoid carcinoma [4]. However, TATE has not been reported in any odontogenic tumors till date. …
Literature
1.
2.
Lorena SCM, Oliveira DT, Dorta RG, Landman G, Kowalski LP (2003) Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia. Oral Dis 9:279–283CrossRefPubMed
3.
Debta P, Debta FM, Chaudhary M, Wadhwan V (2010) Evaluation of infiltration of immunological cells (tissue eosinophil and mast cell) in odontogenic cysts by using special stains. J Clin Cell Immunol 1:103CrossRef
4.
Tasaki T, Matsuyama A, Tabata T, Suzuki H, Yamada S, Sasaguri Y, Hisaoka M (2013) Sclerosing mucoepidermoid carcinoma with eosinophilia of the salivary gland: case report and review of the literature. Pathol Int 63(2):125–131CrossRefPubMed
5.
Fridlender ZG, Simon H-U, Shalit M (2003) Metastatic carcinoma presenting with concomitant eosinophilia and thromboembolism. Am J Med Sci 326:98–101CrossRefPubMed
6.
Mingomataj EC (2008) Eosinophil-induced prognosis improvement of solid tumors could be enabled by their vesicle-mediated barrier permeability induction. Med Hypotheses 70:582–584CrossRefPubMed
7.
Moezzi J, Gopalswamy N, Haas RJ Jr, Markert RJ, Suryaprasad S, Bhutani MS (2000) Stromal eosinophilia in colonic epithelial neoplasms. Am J Gastroenterol 95(2):520–523CrossRefPubMed
8.
Uitto VJ, Ylipaavalniemi P (1977) Alterations in collagenolytic activity caused by jaw fluids. Proc Finn Dent Soc 73:197–202PubMed
9.
de Assis Caldas Pereira F, Gurgel CA, Ramos EA, Vidal MT, Pinheiro AL, Jurisic V, Sales CB, Cury PR, dos Santos JN (2012) Distribution of mast cells in benign odontogenic tumors. Tumour Biol 33(2):455–461CrossRefPubMed
10.
Stewart S, Edward EM (2001) Immunology, immunopathology and immunity, 6th edn. ASM, Washington D.C
Metadata
Title
Tumor Associated Tissue Eosinophilia in Ameloblastoma
Authors
Gargi S. Sarode
Sachin C. Sarode
Amol R. Gadbail
Shailesh Gondivkar
Shankargouda Patil
Publication date
01-07-2019
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2019
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-018-0499-0

Other articles of this Issue 3/2019

Pathology & Oncology Research 3/2019 Go to the issue

Review

MEG3: an Oncogenic Long Non-coding RNA in Different Cancers

Original Article

CDX1/2 and KLF5 Expression and Epigenetic Modulation of Sonic Hedgehog Signaling in Gastric Adenocarcinoma

Original Article

MicroRNA 196B Regulates HOXA5, HOXB6 and GLTP Expression Levels in Colorectal Cancer Cells

Original Article

Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma

Original Article

Clinicopathologic and Immunohistochemical Study of Combined Small Cell Carcinoma and Urothelial Carcinoma Molecular Subtype

Original Article

Predictive Factors of Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits